The Theme of World Stroke Day 2024 Emphasizes Leveraging the Emotional Power of Sports to Raise Stroke Awareness and Encourage Global Action to Reduce Stroke Risk

In the diagnosis of acute ischemic stroke, the combined testing of NSE, S100, and D-dimer (D-D) has shown higher sensitivity and accuracy. NSE is a specific marker for neuronal damage, S100 reflects the extent of brain injury, and D-dimer testing can indicate the potential risk of thrombosis in the body. This combined testing allows for a comprehensive assessment of stroke patients' conditions from different perspectives, effectively reducing the rate of missed diagnoses. Compared to testing a single biomarker, this combination not only improves the accuracy of early diagnosis but also provides doctors with a more complete clinical reference, aiding in the development of more precise treatment plans.

On World Stroke Day, we call on everyone to recognize the importance of combined testing of NSE, S100, and D-dimer, contributing to better stroke diagnosis and treatment, and supporting global stroke prevention efforts. Hotgen mono-test chemiluminescence immunoassay kit and  reagents NSE, S100 and D-dimer joint detection help early and accurate diagnosis of stroke.

#World Stroke Day #Hotgen

https://www.world-stroke.org/world-stroke-day-campaign/world-stroke-day-2024